Imagine a world where damaged tissues and organs can be repaired using a resource readily available in the human body, transforming the landscape of medical treatment as we know it today. This vision is inching closer to reality with the remarkable advancements in fat stem cell research, a field
I'm thrilled to sit down with Ivan Kairatov, a seasoned biopharma expert with a wealth of experience in research and development. With a sharp focus on technology and innovation, Ivan has been at the forefront of advancing biologics formulation, particularly in tackling the complex challenges of
In the high-stakes world of biopharmaceuticals, where developing a single drug can cost upwards of $2.7 billion, inefficiencies in clinical bioanalysis pose a significant threat to timelines and budgets, often delaying critical decisions by weeks or even months. Traditional manual methods,
In the rapidly evolving field of cellular biology, a groundbreaking advancement has emerged that promises to reshape the study of migrasomes, a unique type of organelle critical to cell communication and various physiological processes. These organelles, formed by migrating cells, play essential
The intersection of artificial intelligence and synthetic biology has unlocked groundbreaking possibilities, but it also casts a dark shadow over global biosecurity, as highlighted in a pivotal study recently published in Science . This research reveals how AI-powered generative protein design
In the rapidly advancing realm of synthetic biology, a remarkable innovation is capturing the attention of scientists and industry leaders alike: the potential to produce proteins outside the confines of living cells using synthetic transfer RNA (tRNA) arrays. This cutting-edge development,
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32